Latest Articles
Cyclana Bio raises £5 million to advance novel endometriosis therapies - The Pharma Letter
Cyclana Bio raises £5 million to advance novel endometriosis therapies The Pharma Letter
Published: Oct. 20, 2025, 11:08 a.m.
What do you think of the new endometriosis care plan? - Newstalk
What do you think of the new endometriosis care plan? Newstalk
Published: Oct. 20, 2025, 11 a.m.
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis - Business Wire
Cyclana Bio Raises £5M to Advance Drug Discovery for Endometriosis Business Wire
Published: Oct. 20, 2025, 10:40 a.m.
Cyclana Bio Raises £5M To Advance Drug Discovery for Endometriosis - Technology Networks
Cyclana Bio Raises £5M To Advance Drug Discovery for Endometriosis Technology Networks
Published: Oct. 20, 2025, 10:32 a.m.
Health Minister apologises to women and girls for years of endometriosis neglect - rollercoaster.ie
Health Minister apologises to women and girls for years of endometriosis neglect rollercoaster.ie
Published: Oct. 20, 2025, 9:53 a.m.
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting - Femtech Insider
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting Femtech Insider
Published: Oct. 20, 2025, 8:02 a.m.
My struggle with endometriosis: What started as pelvic pain pushed me to medics, prayers - Daily Monitor
My struggle with endometriosis: What started as pelvic pain pushed me to medics, prayers Daily Monitor
Published: Oct. 20, 2025, 6:21 a.m.
Edna Nyamwaka's struggle with endometriosis: What started as pelvic pain pushed her to medics, prayers - Daily Monitor
Edna Nyamwaka's struggle with endometriosis: What started as pelvic pain pushed her to medics, prayers Daily Monitor
Published: Oct. 20, 2025, 6 a.m.
Lori Harvey Felt ‘Gaslit’ By Docs Who Dismissed 'Excruciating' Symptoms Before Her Life-Changing Diagnosis - AOL.com
Lori Harvey Felt ‘Gaslit’ By Docs Who Dismissed 'Excruciating' Symptoms Before Her Life-Changing Diagnosis AOL.com
Published: Oct. 20, 2025, 5:59 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - BioSpace
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer BioSpace
Published: Oct. 20, 2025, 4:42 a.m.
Link copied to clipboard!